Electrolyte and pH monitoring for fluid removal processes
US-9192707-B2 · Nov 24, 2015 · US
US9814401B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9814401-B2 |
| Application number | US-201313928665-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 27, 2013 |
| Priority date | Jul 6, 2012 |
| Publication date | Nov 14, 2017 |
| Grant date | Nov 14, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A compression device includes at least one pressurizable bladder to substantially occlude blood flow into skin capillary beds adjacent to the at least one pressurizable bladder, and a plurality of perfusion sensors. In operation a first-angiosome sensor detects the perfusion parameter of a skin capillary bed in a first angiosome of the limb, and a second-angiosome sensor detects the perfusion parameter of a skin capillary bed in a second angiosome of the limb that is different from the first angiosome. A control circuit maps sensor signals from the first-angiosome sensor to the first angiosome or a first artery of the limb, and maps sensor signals from the second-angiosome sensor to the second angiosome or a second artery of the limb different from the first artery of the limb. For each perfusion sensor, the control circuit determines whether the received sensor signals are indicative of peripheral artery disease.
Opening claim text (preview).
What is claimed is: 1. An angiosome-based perfusion monitoring system for peripheral artery disease, the monitoring system comprising: a compression device sized and shaped for placement on a limb of a subject, the compression device including: a plurality of pressurizable bladders configured to exert a suitable compressive force on the limb of the subject when pressurized to substantially occlude blood flow into skin capillary beds adjacent to the plurality of pressurizable bladders, and a plurality of spaced apart perfusion sensors, wherein each sensor of the plurality of perfusion sensors is located generally adjacent at least one bladder of the plurality of pressurizable bladders, each perfusion sensor configured to detect a perfusion parameter of skin capillary beds adjacent the perfusion sensor for quantifying skin capillary bed perfusion and generate a signal indicative of the perfusion parameter, wherein at least one sensor of the plurality of perfusion sensors is a first-angiosome sensor for detecting the perfusion parameter of a skin capillary bed in a first angiosome of the limb and at least one sensor of the plurality of perfusion sensors is a second-angiosome sensor for detecting the perfusion parameter of a skin capillary bed in a second angiosome of the limb that is different from the first angiosome, the first-angiosome sensor located generally adjacent a first bladder of the plurality of pressurizable bladders and the second-angiosome sensor located generally adjacent a second bladder of the plurality of pressurizable bladders that is different from the first bladder. 2. The monitoring system of claim 1 , wherein the first-angiosome sensor comprises a plurality of first-angiosome sensors, and wherein the second-angiosome sensor comprises a plurality of second-angiosome sensors. 3. The monitoring system of claim 2 , wherein the first-angiosome sensors are arranged in a first row extending across the first bladder, and wherein the second-angiosome sensors are arranged in a second row, different from the first row, extending across the second bladder. 4. The monitoring system of claim 3 , wherein the first and second rows are spaced apart along a length of the compression device. 5. The monitoring system of claim 2 , wherein the first-angiosome sensors and the second-angiosome sensors are arranged in a same row extending across the first bladder and the second bladder. 6. The monitoring system of claim 1 , wherein the plurality of pressurizable bladders are spaced apart along a length of the compression device, and wherein the compression device is sized and shaped for placement on a leg of the subject. 7. The monitoring system of claim 1 , wherein the perfusion sensors comprise pulse oximetry sensors. 8. The monitoring system of claim 1 , in combination with a control device, the control device comprising: a source of pressurized fluid for introducing into the compression device that is placed on the limb of the subject; and a control circuit configured to: pressurize the first bladder when the compression device is placed on the limb of the subject to substantially occlude blood perfusion in skin capillary beds adjacent to the first bladder, and depressurize the first bladder at a first controlled rate after pressurizing the first bladder, pressurize the second bladder when the compression device is placed on the limb of the subject to substantially occlude blood perfusion in skin capillary beds adjacent to the second bladder, and depressurize the second bladder at a second controlled rate after pressurizing the second bladder, receive separate sensor signals from the first-angiosome sensor and the second-angiosome sensor during respective depressurization of the first bladder and the second bladder, wherein the sensor signals are indicative of perfusion parameters of skin capillary beds adjacent the first-angiosome sensor and the second-angiosome sensor for quantifying skin capillary bed perfusion, map sensor signals from the first-angiosome sensor to at least one of the first angiosome or a first artery of the limb, map sensor signals from the second-angiosome sensor to at least one of the second angiosome or a second artery of the limb different from the first artery of the limb, and determine, for each perfusion sensor, whether the received sensor signals are indicative of peripheral artery disease. 9. The monitoring system of claim 8 , wherein each of the sensors is configured to send an identifier signal to the control device identifying the angiosome or location on the compression device corresponding to the sensor, wherein the control device is configured to receive each identifier signal and determine the location of the sensor based on the sensor identifier. 10. The monitoring system of claim 8 , wherein the control device is configured to selectively pressurize the first bladder and the second bladder. 11. The monitoring system of claim 8 , wherein the first controlled rate and the second controlled rate are the same. 12. The monitoring system of claim 8 , wherein the first controlled rate and the second controlled rate are different. 13. The monitoring system of claim 1 , further comprising a third-angiosome sensor for detecting the perfusion parameter of a skin capillary bed in a third angiosome of the limb, the third-angiosome sensor located generally adjacent one of the first bladder or the second bladder. 14. An angiosome-based perfusion monitoring system for peripheral artery disease, the monitoring system comprising: a control device including: a source of pressurized fluid for introducing into a compression device that is placed on a limb of a subject; and a control circuit configured to: pressurize a first bladder of a plurality of pressurizable bladders of a compression device when the compression device is placed on a limb of a subject to substantially occlude blood perfusion in skin capillary beds adjacent to the first bladder, and depressurize the first bladder at a first controlled rate after pressurizing the first bladder, pressurize a second bladder of the plurality of pressurizable bladders when the compression device is placed on the limb of the subject to substantially occlude blood perfusion in skin capillary beds adjacent to the second bladder, the second bladder being different from the first bladder, and depressurize the second bladder at a second controlled rate after pressurizing the second bladder, receive separate sensor signals from a plurality of perfusion sensors of the compression device during respective depressurization of the first bladder and the second bladder, wherein each sensor of the plurality of perfusion sensors is located generally adjacent at least one bladder of the plurality of pressurizable bladders, and wherein the sensor signals are indicative of perfusion parameters of skin capillary beds adjacent the perfusion sensors for quantifying skin capillary bed perfusion, map sensor signals from a first sensor of the plurality of perfusion sensors to at least one of a first angiosome or a first artery of the limb, the first sensor located generally adjacent the first bladder, map sensor signals from a second sensor of the plurality of perfusion sensors to at least one of a second angiosome or a second artery of the limb, the second sensor located generally adjacent the second bladder, wherein the second angiosome and second artery are different from the first angiosome and the first artery, respectively, and determine, for each perfusion sensor, whether the received sensor signals are indicative of peripheral artery disease. 15. The
Event detection, e.g. detecting unique waveforms indicative of a medical condition (cough events A61B5/0823; seizures A61B5/4094; sleep apnoea A61B5/4818) · CPC title
using correlation, e.g. template matching or determination of similarity · CPC title
Comprising radiolucent components · CPC title
Evaluating blood vessel condition, e.g. elasticity, compliance · CPC title
for measuring blood gases · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.